Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: Clin Cancer Res. 2012 May 15;18(13):3677–3685. doi: 10.1158/1078-0432.CCR-11-3209

Table 4.

Changes in biochemicals relevant to insulin resistance from baseline to three months

SUB PATHWAY BIOCHEMICAL NAME Fold of change, Month 3 vs. Baseline p-value for paired t-test, Month 3 vs. Baseline q-value for paired t-test, Month 3 vs. Baseline
2-hydroxybutyrate (2-HB) 0.84 0.030 0.120
Valine, leucine and isoleucine metabolism 3-methyl-2-oxobutyrate 0.96 0.553 0.4393
3-methyl-2-oxovalerate 0.99 0.548 0.4391
beta-hydroxyisovalerate 0.94 0.203 0.3186
isoleucine 0.91 0.066 0.1959
leucine 0.93 0.118 0.2544
valine 0.94 0.272 0.3558
2-hydroxyisobutyrate 1.02 0.856 0.5260
3-hydroxyisobutyrate 0.94 0.328 0.3558
4-methyl-2-oxopentanoate 0.97 0.546 0.4386
alpha-hydroxyisovalerate 0.91 0.016 0.0915
isobutyrylcarnitine 1.01 0.802 0.5115
2-methylbutyroylcarnitine 0.88 0.039 0.1414
isovalerylcarnitine 0.99 0.475 0.4135
hydroxyisovaleroyl carnitine 0.97 0.797 0.5115
tiglyl carnitine 0.98 0.839 0.5222
methylglutaroylcarnitine 0.86 0.072 0.2018

• All values are normalized in terms of raw area counts.

• “Fold change Month 3 vs. Baseline” denotes <month 3 level> divided by <baseline level> of each biochemical (i.e. fold change of 0.76 denotes a 24% decrease).

• Shading corresponds to degree of change. Thresholds for color intensity are as follows: green denotes ≤ 0.65 fold change, dark green denotes 0.65 - 0.95 fold change, black denotes 0.95 – 1.05 fold change, dark red denotes 1.05 – 1.35 fold change, red denotes ≥ 1.35 fold change.